BETA: Please send your feedback!
Chromadex
CDXC:NAS
Chemicals: Specialty
$0
SMALL cap
$3.48
(0.00%)
-0.20%
since start of 2020
-6.17
About
Chemicals: Specialty
Founded 1999
Chromadex Corp. engages in acquiring, developing, and commercializing proprietary-based ingredient technologies through its business model. It operates through the following segments: Ingredients, Core Standards and Contract Services, and Regulatory Consulting. The Ingredients segment offers developing and commercializing proprietary-based ingredient technologies. The Core Standards and Contract Services segment involves focuses on natural product fine chemicals, chemistry, and analytical testing services. The Regulatory Consulting segment offers consulting projects for customers in Europe, South, America, and Asia. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in September 1999 and is headquartered in Irvine, CA.
website
Headquarters
Executives
| Name | Title | Gender |
| Troy Allen Rhonemus | Chief Operating Officer | Male |
| Mark S. Germain | Founder | Male |
| Frank L. Jaksch, Jr. | President, Chief Executive Officer & Director | Male |
| Thomas C. Varvaro, CPA | CFO, Secretary & Principal Accounting Officer | Male |
| James D. McChesney, PhD | Chief Scientific Officer | Male |
| Stephen Allen | Non-Executive Chairman | Male |
| Andrew Johnson | Director-Investor Relations | Male |
Mindful Investing Summary
Chromadex - Competitors and Related Companies
How Chromadex stacks up to its peers in the Chemicals: Specialty industry or with competing business segments.
Chromadex
CDXC:NAS
Chemicals: Specialty
$0
SMALL cap
$3.48
(0.00%)
-0.20%
since start of 2020
-6.17
Loading…